06855 ASCENTAGE-B
- 40.950
- -0.300-0.73%
About ASCENTAGE-B Company
Ascorbic Pharma is a globally focused clinical-stage biotechnology company dedicated to developing novel therapies for cancer, the hepatitis B virus, and age-related diseases. The company focuses on developing treatments that inhibit protein-protein interactions to restore apoptosis or programmed cell death. Ascorbic Pharma has established new products including eight drug candidates, including novel, highly effective Bcl-2/Bcl-XL inhibitors, candidates targeting the IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. The company has conducted 28 phase I/II clinical trials to evaluate eight products from the US, Australia, and China to develop potential treatments as single drugs or combination drugs.
Company Profile
Company Executives
- Name
- Position
- Salary
- dajun yang
- Chairman of the Board, CEOs, Executive Director, Chairman of the Nomination Committee, Remuneration Committee Members, Authorized Representative
- 4.78M
- shaomeng wang
- Non-executive Directors, Chairman of the Scientific Advisory Board
- 1.17M
- dazhong lv
- Non-executive Directors, Audit Committee Members
- 25.00K
- zhangqing ye
- Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members
- 502.00K
- wei ren
- Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
- 502.00K
- David Sidransky
- Independent Non-Executive Director, Nomination Committee Members
- 510.00K
- yifan di
- Chief Medical Officer
- --
- Raymond Jeffrey KMETZ
- Chief Commercial Officer
- --
- Thomas Joseph KNAPP
- Senior Vice President, General Counsel
- --
- zhangqi wang
- Authorized Representative, Company Secretary
- --
- gang zhu
- Chief Commercial Operations Officer
- --
Analysis
Price Target
No Data
No Data